The present invention relates to methods and products for the evaluation
of HIV treatment. In particular, molecular events at the HIV envelope
protein and their effect on therapeutic efficacy of drugs are determined.
The methods rely on providing HIV envelope nucleic acid material and
evaluating a treatment either through genotyping or phenotyping. Said
method may find use in multiple fields including diagnostics, drug
screening, pharmacogenetics and drug development.